Your browser doesn't support javascript.
loading
Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.
Puricelli Perin, Douglas M; Elfström, K Miriam; Bulliard, Jean-Luc; Burón, Andrea; Campbell, Christine; Flugelman, Anath A; Giordano, Livia; Kamineni, Aruna; Ponti, Antonio; Rabeneck, Linda; Saraiya, Mona; Smith, Robert A; Broeders, Mireille J M.
  • Puricelli Perin DM; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Electronic address: douglas.puricelliperin@nih.gov.
  • Elfström KM; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Regional Cancer Center of Stockholm Gotland, Stockholm, Sweden.
  • Bulliard JL; Center for Primary Care and Public Health (unisanté), University of Lausanne, Lausanne, Switzerland.
  • Burón A; Epidemiology and Evaluation Department, Hospital del Mar, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; REDISSEC (Health Services Research on Chronic Patients Network), Madrid, Spain.
  • Campbell C; Usher Institute, University of Edinburgh, Scotland, UK.
  • Flugelman AA; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Clalit National Cancer Control Center, Haifa, Israel.
  • Giordano L; SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
  • Kamineni A; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Ponti A; SSD Epidemiologia e screening - CPO, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
  • Rabeneck L; Prevention and Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Saraiya M; Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Smith RA; American Cancer Society, Atlanta, GA, USA.
  • Broeders MJM; Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands; Dutch Expert Centre for Screening, Nijmegen, the Netherlands.
Prev Med ; 151: 106642, 2021 10.
Article en En | MEDLINE | ID: mdl-34217420
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research / Screening_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article